"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley.
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Podcast - Episode 2, Series 5
January 30, 2026 - - Podcast -
International HTA Collaboration continues as global pricing pressures evolve
January 29, 2026 - - Latest News -
How an Australian Campaign Is tackling the silent epidemic of heart and kidney disease
January 29, 2026 - - Latest News -
ARCS warns workforce gaps threaten returns on clinical trials reform
January 29, 2026 - - Latest News -
AstraZeneca appoints new country president as Ben McDonald transitions to global role
January 29, 2026 - - Latest News -
Why do some appear so uncomfortable with this group of people getting help?
January 29, 2026 - - Latest News -
New digital health reforms to give Australians a more complete medicines history
January 28, 2026 - - Latest News

